期刊文献+

海南地区淋巴瘤组织学类型的分布特点

下载PDF
导出
摘要 淋巴瘤或称恶性淋巴瘤(malignant lymphoma,ML)是指原发于淋巴结或结外淋巴组织的淋巴细胞及其前体细胞的恶性肿瘤。淋巴瘤的发生率在我国恶性肿瘤中排第10位,是儿童和青少年最常见的恶性肿瘤。淋巴瘤的分布具有较明显的地区特征,如地方性伯基特淋巴瘤主要分布于非洲赤道附近,而T细胞性非何奇金淋巴瘤(T—NHL)则以中国和亚洲多见。
出处 《第三军医大学学报》 CAS CSCD 北大核心 2011年第5期501-501,510,共2页 Journal of Third Military Medical University
  • 相关文献

参考文献5

  • 1李兰芳,任秀宝.恶性淋巴瘤疫苗治疗的进展[J].中国新药杂志,2010,19(10):837-840. 被引量:1
  • 2秦鑫添,吕跃,陈晓勤,徐海鹏,樊慧杰.HBV感染与非霍奇金淋巴瘤的关系[J].癌症,2007,26(3):294-297. 被引量:30
  • 3Takeshita M, Sakai H, Okamura S, et al. Splenic large B-cell lymphoma in patients with hepatitis C virus infection [ J ]. Hum Pathol, 2005, 36 (8): 878- 885.
  • 4Jeong S H. HBV infection as a risk factor for non-Hodgkin lymphoma [J]. Lancet Oncol, 2010, 11(9): 806.
  • 5李敏,刘翠苓,黄欣,等.中国人淋巴瘤不同病理学类型的分布特点分析[C]//第十一届中国抗癌协会全国淋巴瘤学术大会教育论文集.天津:中国抗癌协会,2009:455-456.

二级参考文献36

  • 1刘华,王蔚,陈俊民,郑垂志.乙型肝炎病毒感染与恶性淋巴瘤关系的探讨[J].白血病.淋巴瘤,2005,14(1):27-28. 被引量:21
  • 2罗耀星,张吉凯,李建基,李辉,蔡汉港,方苓,陆碧如,阳文胜.广东省2002年病毒性肝炎血清流行病学调查分析[J].中国计划免疫,2005,11(2):89-92. 被引量:51
  • 3COLOMBAT P, SALLES G, BROUSSE N, et al. Rituximab (anti-CD20 monoclonal antibody) as single first-line therapy for patients with follicular lymphoma with a low tumor burden : clinical and molecular evaluation [ J ]. Blood, 2001,97 ( 1 ) : 101 - 106.
  • 4BERTINETTI C, ZIRLIK K, HEINING-MIKESCH K, et al. Phase I trial of a novel intradermal idiotype vaccine in patients with advanced B-cell lymphoma: specific immune responses despite profound immunosuppression [ J ]. Cancer Res, 2006, 66 (8) :4496 -4502.
  • 5REDFERN CH, GUTHRIE TH, BESSUDO A, et al. Phase II trial of idiotype vaccination in previously treated patients with indolent non-Hodgkin's lymphoma resulting in durable clinical responses [ J ]. J Clin Oncol, 2006, 24 ( 19 ) :3107 - 3112.
  • 6BARRIOS Y, CABRERA R, YANEZ R, et al. Anti-idiotypic vaccination in the treatment of low-grade B-cell lymphoma [ J ]. ttaematologica, 2002, 87(4):400-407.
  • 7INOGES S, RODRIGUEZ-CALVILLO M, ZABALEGUI N, et al. Clinical benefit associated with idiotypic vaccination in patients with follicular lymphoma [ J ]. J Natl Cancer Inst, 2006, 98 (18) : 1292 -301.
  • 8HOLLANDER N. Current vaccination strategies for the treatment of B-cell lymphoma and muhiple myeloma [ J ]. Crit Rev Immunol, 2009, 29(5): 399-418.
  • 9TIMMERMAN JM, CZERWINSKI DK, DAVIS TA, et al. Idiotype-pulsed dendritic cell vaccination for B-celt lymphoma: clini- cal and immune responses in 35 patients[J]. Blood, 2002, 99 (5) :1517 - 1526.
  • 10TIMMERMAN JM, VOSE JM, CZERWINSKI DK,et al. Tumor-specific recombinant idiotype immunisation after chemotherapy as initial treatment for follicular non-Hodgkin lymphoma[ J]. Leuk Lymphoma, 2009, 50( 1 ) :37 -46.

共引文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部